TECON BIOLOGY Co.LTD (SHE:002100)

China · Delayed Price · Currency is CNY

6.99

-0.23 (-3.19%)

Aug 4, 2026, 3:04 PM CST

8.71% (1Y)

Market Cap	9.54B +8.7%
Revenue (ttm)	16.72B -4.9%
Net Income	-100.79M
EPS	-0.07
Shares Out	1.37B
PE Ratio	n/a
Forward PE	30.36
Dividend	0.08 (1.08%)
Ex-Dividend Date	Jun 10, 2026

Volume	28,022,260
Open	7.23
Previous Close	7.22
Day's Range	6.92 - 7.23
52-Week Range	5.64 - 8.46
Beta	0.46
Analysts	Strong Buy
Price Target	8.15 (+16.6%)
Earnings Date	Aug 27, 2026

About TECON BIOLOGY Co.LTD

TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the feed processing, pig and poultry breeding, slaughtering and meat processing, animal vaccine production, cottonseed processing, corn storage, and agricultural and livestock guarantees in China and internationally. It offers inactivated vaccines against foot-and-mouth disease, a series of vaccines for ruminants and pigs, avian influenza vaccines, and animal disease diagnostic reagents; edible cottonseed oil and high-end dephenolized cottonseed protein products; and feed products... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1993

Employees 4,803

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002100

Full Company Profile

Financial Performance

In 2025, TECON BIOLOGY Co.LTD's revenue was 16.98 billion, a decrease of -1.13% compared to the previous year's 17.18 billion. Earnings were 210.63 million, a decrease of -65.19%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 002100 stock is "Strong Buy." The 12-month stock price target is ¥8.15, which is an increase of 16.60% from the latest price.

Price Target

¥8.15

(16.60% upside)

Analyst Consensus: Strong Buy

Stock Forecasts